申请人:Lai Kent
公开号:US20110251236A1
公开(公告)日:2011-10-13
Therapeutic agents for treatment of Galactosemia and disorders thereof, and other enzyme related disorders thereof are identified. The compounds inhibit galactokinase (GALK) and other kinase activity and are identified by a high throughput screening assay.